Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis.
A total of 150 women in 3 equal groups, each using a different contraceptive method (group I used Norplant, group II used the IUD and group III used combined OC pills) were investigated for the presence of vaginal candidiasis before and at various time intervals (3, 6 and 12 months) after starting to use the particular contraceptive method. The incidence of vaginal Candida albicans infection increased significantly among pill and IUD users, but with a much lower intensity among the latter cases. In Norplant users the increase was slight and insignificant. The explanation of these findings within the context of changes in local vaginal milieu is discussed.
D000328:Adult; D002181:Candidiasis, Vulvovaginal / Q000209:etiology*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D004343:Drug Implants; D005260:Female; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects; D016912:Levonorgestrel; D009644:Norgestrel / Q000008:administration & dosage* / Q000009:adverse effects
D003277:Contraceptives, Oral, Combined; D004343:Drug Implants; D009644:Norgestrel; D016912:Levonorgestrel